Prospective Observational Epidemiologic Study of Maraviroc's Safety

Completed

Conditions studied: Human Immunodeficiency Virus

In brief

The study will assess if use of maraviroc along with an optimized background regimen of antiretroviral drugs in usual clinical practice is as safe as using only an optimized regimen of antiretroviral drugs.

Key facts

Study ID
NCT00665561
Run by
ViiV Healthcare
People needed
2500
Starts
2008-03-31
Expected to finish
2019-02-14
Last updated by the study team
2022-10-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.